Oncocyte annual meeting elects directors, ratifies auditor; Board confirms Arno independence

Insight Molecular Diagnostics Inc.

Shareholders elected four director nominees (Riggs, Arno, Last, Silverman) with ~7.98M votes each; quorum 81.5%.
Ratified Marcum LLP as auditor for FY2024: 10.8M for, 10.9k against, 11k abstain.
Approved non-binding say-on-pay proposal: 8.12M for, 20k against, 11k abstain.
Board determined Andrew Arno independent per Nasdaq rules as of July 1, 2024; Arno chairs Compensation, Last chairs Audit, Silverman chairs Nominating.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.